Novel Therapies in the Treatment of Atopic Dermatitis: Advances and Challenges

Abstract

Atopic dermatitis (AD), a chronic inflammatory skin condition, remains one of the most

common dermatological diseases, significantly impacting patients' quality of life. Despite

conventional therapies such as topical corticosteroids and immunosuppressive agents, there

has been a growing interest in novel therapeutic approaches targeting the underlying immune

pathways. This paper explores recent advances in the treatment of AD, with a particular focus

on biologic agents, Janus kinase (JAK) inhibitors, and emerging topical therapies.

Additionally, the paper discusses the challenges associated with these novel treatments,

including their safety profiles, accessibility, and long-term effectiveness. By highlighting

both progress and obstacles, this review aims to provide a comprehensive overview of the

current state of AD treatment and future directions.